中华医院管理杂志
中華醫院管理雜誌
중화의원관리잡지
CHINESE JOURNAL OF HOSPITAL ADMINISTRATION
2013年
2期
84-87
,共4页
赵要军%谢双保%吴建%皇甫嘉鑫%张静%冯占春
趙要軍%謝雙保%吳建%皇甫嘉鑫%張靜%馮佔春
조요군%사쌍보%오건%황보가흠%장정%풍점춘
临床路径%分组管理%政府购买%医疗服务
臨床路徑%分組管理%政府購買%醫療服務
림상로경%분조관리%정부구매%의료복무
Clinical pathway%Grouping management%Govemment procurement%Medical service
为有效解决当前单病种临床路径管理纳入率低、退出率高的问题,在传统临床路径管理的基础上,根据DRGs分组管理的思想,结合我国实际,提出了按病种分组管理的理念,通过引入质量控制机制、价格谈判机制、绩效支付机制和监督管理机制等政府购买服务的措施,旨在实现调动医疗机构和医务人员积极性,控制医疗费用不合理增长,优化费用结构,提高医疗服务质量和患者满意度等目标.河南省借助中国农村卫生发展项目,试行按病种临床路径分组管理理念和政府购买服务方式后,病种覆盖范围和覆盖人群明显扩大,患者次均费用水平得到了有效控制,体现医护人员劳务价值的手术和治疗费用不断提升,药品占比由改革前的约50%,下降到了30%以下的平均水平,医疗费用构成比逐渐优化,医疗质量也明显改善,使得医、保、患三方都满意.
為有效解決噹前單病種臨床路徑管理納入率低、退齣率高的問題,在傳統臨床路徑管理的基礎上,根據DRGs分組管理的思想,結閤我國實際,提齣瞭按病種分組管理的理唸,通過引入質量控製機製、價格談判機製、績效支付機製和鑑督管理機製等政府購買服務的措施,旨在實現調動醫療機構和醫務人員積極性,控製醫療費用不閤理增長,優化費用結構,提高醫療服務質量和患者滿意度等目標.河南省藉助中國農村衛生髮展項目,試行按病種臨床路徑分組管理理唸和政府購買服務方式後,病種覆蓋範圍和覆蓋人群明顯擴大,患者次均費用水平得到瞭有效控製,體現醫護人員勞務價值的手術和治療費用不斷提升,藥品佔比由改革前的約50%,下降到瞭30%以下的平均水平,醫療費用構成比逐漸優化,醫療質量也明顯改善,使得醫、保、患三方都滿意.
위유효해결당전단병충림상로경관리납입솔저、퇴출솔고적문제,재전통림상로경관리적기출상,근거DRGs분조관리적사상,결합아국실제,제출료안병충분조관리적이념,통과인입질량공제궤제、개격담판궤제、적효지부궤제화감독관리궤제등정부구매복무적조시,지재실현조동의료궤구화의무인원적겁성,공제의료비용불합리증장,우화비용결구,제고의료복무질량화환자만의도등목표.하남성차조중국농촌위생발전항목,시행안병충림상로경분조관리이념화정부구매복무방식후,병충복개범위화복개인군명현확대,환자차균비용수평득도료유효공제,체현의호인원노무개치적수술화치료비용불단제승,약품점비유개혁전적약50%,하강도료30%이하적평균수평,의료비용구성비축점우화,의료질량야명현개선,사득의、보、환삼방도만의.
For the purpose of resolving such current problems as low inclusion ratio and high exit ratio in the single-disease clinical pathway management,the paper proposed an idea of clinical pathways grouping management,in line with DRG management and based on traditional clinical pathway management practice and China' s conditions.Proposed in the paper are such measures for government service procurement,as quality control mechanism,price negotiation mechanism,performance-based payment mechanism,and supervision mechanism.These measures are designed to provide incentives for medical institutions and medical workers,control irrational rise of medical expense,optimize expense makeup,and improve both quality of care and patient satisfaction.Thanks to the China Rural Health Development Project in place in Henan province where DRG-based clinical pathway grouping management and government service procurement are in trials,the following outcomes are achieved.Namely,significant expansion of diseases coverage and population coverage,efficient control of per-patient/per-visit expenses,and a steady rise of surgery and treatment expenses which embody value of service of medical workers.Other benefits include 50% to less than 30%drop of drugs proportion,gradual optimization of medical expenses makeup,obvious improvement of quality of care.These measures have made hospitals,insurance providers and patients satisfactory.